John E. Elicker | Bristol-Myers Squibb Co. |
Giovanni Caforio | Bristol-Myers Squibb Co. |
Charles A. Bancroft | Bristol-Myers Squibb Co. |
Thomas J. Lynch, Jr., M.D. | Bristol-Myers Squibb Co. |
Christopher S. Boerner | Bristol-Myers Squibb Co. |
Johanna Mercier | Bristol-Myers Squibb Co. |
Gregg Gilbert | Deutsche Bank Securities, Inc. |
Jami Rubin | Goldman Sachs & Co. LLC |
Christopher Schott | JPMorgan Securities LLC |
Olivia Brayer | Barclays Capital, Inc. |
Jason M. Gerberry | Bank of America Merrill Lynch |
Andrew S. Baum | Citigroup Global Markets Ltd. |
Alex Arfaei | BMO Capital Markets (United States) |
David R. Risinger | Morgan Stanley & Co. LLC |
Steve Scala | Cowen & Co. LLC |
Umer Raffat | Evercore ISI |
Vamil K. Divan | Credit Suisse Securities (NYSE:USA) LLC |
John T. Boris | SunTrust Robinson Humphrey, Inc. |
Matthew Phipps | William Blair & Co. LLC |
Good day, and welcome to the Bristol-Meyers Squibb 2018 Second Quarter Results Conference Call. Today's call is being recorded. At this time, I'll turn the conference over to Mr. John Elicker, Senior Vice President, Public Affairs and Investor Relations. Please go ahead.